CD274 and neoplasm: Most importantly, independently of the underlying mechanisms, the data in the study by Chen et al. [1] are clinically relevant, demonstrating the synergistic anti-tumor effect of 3-OBA, metformin and PD-1/PD-L1 blockade in vivo.